No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Has DexCom (DXCM) Outpaced Other Medical Stocks This Year?
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2023 Earnings Call Transcript
Anika Therapeutics Full Year 2023 Earnings: EPS Misses Expectations
Express News | Barrington Research Maintains Outperform on Anika Therapeutics, Raises Price Target to $37
Anika Therapeutics: Strong Q4 Performance and Upbeat FY2024 Outlook Justify Buy Rating and Raised Price Target
Express News | Stephens & Co. Reiterates Equal-Weight on Anika Therapeutics, Maintains $22 Price Target
No Data